TY - JOUR
T1 - International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder
AU - Crunelle, Cleo L.
AU - van den Brink, Wim
AU - Moggi, Franz
AU - Konstenius, Maija
AU - Franck, Johan
AU - Levin, Frances R.
AU - van de Glind, Geurt
AU - Demetrovics, Zsolt
AU - Coetzee, Corné
AU - Luderer, Mathias
AU - Schellekens, Arnt
AU - Matthys, Frieda
PY - 2018
Y1 - 2018
N2 - Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (SUD) and is associated with early onset and more severe development of SUD and with reduced treatment effectiveness. Screening tools allow for a good recognition of possible ADHD in adults with SUD and should be used routinely, followed by an ADHD diagnostic process initiated as soon as possible. Simultaneous and integrated treatment of ADHD and SUD, using a combination of pharmaco- and psychotherapy, is recommended. Long-acting methylphenidate, extended-release amphetamines, and atomoxetine with up-titration to higher dosages may be considered in patients unresponsive to standard doses. This paper includes evidence- and consensus-based recommendations developed to provide guidance in the screening, diagnosis and treatment of patients with ADHD-SUD comorbidity.
AB - Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (SUD) and is associated with early onset and more severe development of SUD and with reduced treatment effectiveness. Screening tools allow for a good recognition of possible ADHD in adults with SUD and should be used routinely, followed by an ADHD diagnostic process initiated as soon as possible. Simultaneous and integrated treatment of ADHD and SUD, using a combination of pharmaco- and psychotherapy, is recommended. Long-acting methylphenidate, extended-release amphetamines, and atomoxetine with up-titration to higher dosages may be considered in patients unresponsive to standard doses. This paper includes evidence- and consensus-based recommendations developed to provide guidance in the screening, diagnosis and treatment of patients with ADHD-SUD comorbidity.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85043691935&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/29510390
U2 - https://doi.org/10.1159/000487767
DO - https://doi.org/10.1159/000487767
M3 - Review article
C2 - 29510390
SN - 1022-6877
VL - 24
SP - 43
EP - 51
JO - European Addiction Research
JF - European Addiction Research
IS - 1
ER -